ReviewFrontiers in molecular biosciences2024

Targeting Death Receptor 5 (DR5) for the imaging and treatment of primary bone and soft tissue tumors: an update of the literature.

Zakareya Gamie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.